iridex-logo-tag.png
IRIDEX to Present at the 2019 Stifel Healthcare Conference
November 05, 2019 16:05 ET | IRIDEX Corporation
MOUNTAIN VIEW, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Healthcare Conference in New York...
iridex-logo-tag.png
IRIDEX Announces Appointment of Robert Gunst as Chairman of the Board of Directors and Departure of Lead Independent Director, Ruediger Naumann-Etienne
October 28, 2019 16:05 ET | IRIDEX Corporation
MOUNTAIN VIEW, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Robert Gunst as Chairman of the Board, effective October 23, 2019....
iridex-logo-tag.png
IRIDEX to Report Third Quarter 2019 Financial Results on November 7, 2019
October 24, 2019 16:03 ET | IRIDEX Corporation
MOUNTAIN VIEW, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the third quarter of 2019 after the close of...
iridex-logo-tag.png
MicroPulse® Transscleral Laser Therapy Will be Discussed in Various Presentations and Educational Events at ESCRS 2019 in Paris, France
September 11, 2019 17:11 ET | IRIDEX Corporation
MOUNTAIN VIEW, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
iridex-logo-tag.png
IRIDEX Announces 2019 Second Quarter Financial Results
August 06, 2019 16:03 ET | IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 29, 2019. Second Quarter Highlights ...
iridex-logo-tag.png
IRIDEX to Report Second Quarter 2019 Financial Results on August 6, 2019
July 23, 2019 16:05 ET | IRIDEX Corporation
MOUNTAIN VIEW, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2019 after the close...
iridex-logo-tag.png
IRIDEX Announces Leadership Transition; David Bruce Appointed President and CEO
May 21, 2019 16:03 ET | IRIDEX Corporation
MOUNTAIN VIEW, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
iridex-logo-tag.png
IRIDEX Announces 2019 First Quarter Financial Results
May 02, 2019 16:12 ET | IRIDEX Corporation
MOUNTAIN VIEW, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended March 30, 2019. First Quarter Highlights ...
iridex-logo-tag.png
IRIDEX’s MicroPulse® Laser Technology Featured in Several Glaucoma and Retina Research Presentations at Major Ophthalmic Industry Conferences
April 29, 2019 14:41 ET | IRIDEX Corporation
MOUNTAIN VIEW, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...
iridex-logo-tag.png
Scott Shuda Appointed to IRIDEX Board of Directors
April 29, 2019 08:00 ET | IRIDEX Corporation
MOUNTAIN VIEW, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and...